144 related articles for article (PubMed ID: 32526448)
1. Exploratory study of association between blood immune markers and cognitive symptom severity in major depressive disorder: Stratification by body mass index status.
Fourrier C; Sampson E; Hori H; Schubert KO; Clark S; Mills NT; Baune BT
Brain Behav Immun; 2020 Aug; 88():242-251. PubMed ID: 32526448
[TBL] [Abstract][Full Text] [Related]
2. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with objective and subjective cognitive impairment in Chinese patients with acute major depressive disorder.
Zhu N; Tong J; Pei Y; Zhang J; Sun X
BMC Psychiatry; 2023 May; 23(1):348. PubMed ID: 37208711
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): Association with psychosocial function in major depressive disorder.
Cha DS; Carmona NE; Subramaniapillai M; Mansur RB; Lee Y; Hon Lee J; Lee J; Rosenblat JD; Shekotikhina M; Park C; Rong C; Greer TL; Lam R; Baune BT; Harrison J; McIntyre RS
J Affect Disord; 2017 Nov; 222():14-20. PubMed ID: 28667888
[TBL] [Abstract][Full Text] [Related]
5. Emotional Blunting in Depression in the PREDDICT Clinical Trial: Inflammation-Stratified Augmentation of Vortioxetine With Celecoxib.
Sampson E; Kavakbasi E; Mills NT; Hori H; Schubert KO; Fourrier C; Baune BT
Int J Neuropsychopharmacol; 2024 Mar; 27(3):. PubMed ID: 38441216
[TBL] [Abstract][Full Text] [Related]
6. Exploratory Analysis of the Effects of Celecoxib on Cognitive Function in Vortioxetine-Treated Patients With Major Depressive Disorder in the PREDDICT Study: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Sampson E; Mills NT; Hori H; Schwarte K; Hohoff C; Schubert O; Clark SR; Fourrier C; Baune BT
J Clin Psychiatry; 2023 Oct; 84(6):. PubMed ID: 37796652
[No Abstract] [Full Text] [Related]
7. Cognitive Deficits in the THINC-Integrated Tool (THINC-it) Are Associated With Psychosocial Dysfunction in Patients With Major Depressive Disorder.
Knight MJ; Fourrier C; Lyrtzis E; Aboustate N; Sampson E; Hori H; Mills NT; Baune BT
J Clin Psychiatry; 2018 Nov; 80(1):. PubMed ID: 30549482
[TBL] [Abstract][Full Text] [Related]
8. Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder.
Cha DS; Carmona NE; Rodrigues NB; Mansur RB; Lee Y; Subramaniapillai M; Phan L; Cha RH; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Rosenblat JD; Shekotikhina M; Rong C; Harrison J; McIntyre RS
J Affect Disord; 2018 Oct; 238():228-232. PubMed ID: 29886204
[TBL] [Abstract][Full Text] [Related]
9. Association between cognitive function and performance on effort based decision making in patients with major depressive disorder treated with Vortioxetine.
Subramaniapillai M; Mansur RB; Zuckerman H; Park C; Lee Y; Iacobucci M; Cao B; Ho R; Lin K; Phan L; McIntyre RS
Compr Psychiatry; 2019 Oct; 94():152113. PubMed ID: 31404802
[TBL] [Abstract][Full Text] [Related]
10. The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change.
McIntyre RS; Subramaniapillai M; Park C; Zuckerman H; Cao B; Lee Y; Iacobucci M; Nasri F; Fus D; Bowie CR; Tran T; Rosenblat JD; Mansur RB
Front Psychiatry; 2020; 11():546. PubMed ID: 32670103
[TBL] [Abstract][Full Text] [Related]
11. The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.
McIntyre RS; Best MW; Bowie CR; Carmona NE; Cha DS; Lee Y; Subramaniapillai M; Mansur RB; Barry H; Baune BT; Culpepper L; Fossati P; Greer TL; Harmer C; Klag E; Lam RW; Wittchen HU; Harrison J
J Clin Psychiatry; 2017 Jul; 78(7):873-881. PubMed ID: 28858441
[TBL] [Abstract][Full Text] [Related]
12. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression.
Köhler-Forsberg O; Buttenschøn HN; Tansey KE; Maier W; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; Rietschel M; McGuffin P; Aitchison KJ; Uher R; Mors O
Brain Behav Immun; 2017 May; 62():344-350. PubMed ID: 28257825
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled, hybrid parallel-arm study of low-dose naltrexone as an adjunctive anti-inflammatory treatment for major depressive disorder.
Plank JR; Glover SC; Moloney BD; Hoeh NR; Sundram F; Sumner RL; Muthukumaraswamy S; Lin JC
Trials; 2022 Sep; 23(1):822. PubMed ID: 36175917
[TBL] [Abstract][Full Text] [Related]
14. PSYCHOMETRIC properties of the Chinese version of the THINC-it tool for cognitive symptoms in patients with major depressive disorder.
Hou Y; Yao S; Hu S; Zhou Q; Han H; Yu X; McIntyre RS; Shi C
J Affect Disord; 2020 Aug; 273():586-591. PubMed ID: 32560957
[TBL] [Abstract][Full Text] [Related]
15. Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin.
Berk M; Mohebbi M; Dean OM; Cotton SM; Chanen AM; Dodd S; Ratheesh A; Amminger GP; Phelan M; Weller A; Mackinnon A; Giorlando F; Baird S; Incerti L; Brodie RE; Ferguson NO; Rice S; Schäfer MR; Mullen E; Hetrick S; Kerr M; Harrigan SM; Quinn AL; Mazza C; McGorry P; Davey CG
BMC Med; 2020 Jan; 18(1):16. PubMed ID: 31948461
[TBL] [Abstract][Full Text] [Related]
16. Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response.
Dreimüller N; Lieb K; Tadić A; Engelmann J; Wollschläger D; Wagner S
J Affect Disord; 2019 Sep; 256():524-531. PubMed ID: 31280076
[TBL] [Abstract][Full Text] [Related]
17. Digging deeper in the differential effects of inflammatory and psychosocial stressors in remitted depression: Effects on cognitive functioning.
Niemegeers P; de Boer P; Schuermans J; Dumont GJH; Coppens V; Spittaels K; Claes S; Sabbe BGC; Morrens M
J Affect Disord; 2019 Feb; 245():356-363. PubMed ID: 30423462
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind, placebo-controlled, crossover trial evaluating the effect of intranasal insulin on cognition and mood in individuals with treatment-resistant major depressive disorder.
Cha DS; Best MW; Bowie CR; Gallaugher LA; Woldeyohannes HO; Soczynska JK; Lewis G; MacQueen G; Sahakian BJ; Kennedy SH; Lui JP; Mansur RB; McIntyre RS
J Affect Disord; 2017 Mar; 210():57-65. PubMed ID: 28013123
[TBL] [Abstract][Full Text] [Related]
19. The Relationship Between Cognitive Dysfunction Through THINC-Integrated Tool (THINC-it) and Psychosocial Function in Chinese Patients With Major Depressive Disorder.
Han H; Hou Y; Yao S; Hu S; Zhou Q; Yu X; McIntyre RS; Shi C
Front Psychiatry; 2021; 12():763603. PubMed ID: 34887790
[No Abstract] [Full Text] [Related]
20. Assessing Reliability and Validity of the Oxford Depression Questionnaire (ODQ) in a Japanese Clinical Population.
Kato M; Kikuchi T; Watanabe K; Sumiyoshi T; Moriguchi Y; Åström DO; Christensen MC
Neuropsychiatr Dis Treat; 2023; 19():2401-2412. PubMed ID: 38029050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
